Samjin Pharm (005500) — Cash Flow Reinvestment Rate
Samjin Pharm (005500) has a Cash Flow Reinvestment Rate of 0.93x as of June 2025, reinvesting ₩9.90 Billion (capex ₩3.78 Billion plus investments ₩-6.12 Billion) from operating cash flow of ₩10.63 Billion. Check 005500 operating cash flow to net income to evaluate the quality of earnings relative to operating cash generation.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Samjin Pharm Cash Flow Reinvestment Rate (2013–2024)
Historical reinvestment intensity for Samjin Pharm across 12 annual periods. Explore Samjin Pharm strategic investment ratio to see how much of total assets are deployed in long-term investments.
Annual Cash Flow Reinvestment Rate for Samjin Pharm (2013–2024)
Year-by-year capital reinvestment analysis for Samjin Pharm. For live market cap and broader valuation context, see market cap of Samjin Pharm.
| Year | Reinvestment Rate | Total Reinvested (KRW) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.50x | ₩19.21 Billion | ₩38.15 Billion | ₩18.34 Billion | ▼ -89.2% |
| 2023 | 4.68x | ₩38.97 Billion | ₩8.33 Billion | ₩20.72 Billion | ▼ -23.4% |
| 2022 | 6.10x | ₩105.56 Billion | ₩17.29 Billion | ₩35.50 Billion | ▲ +0.1% |
| 2021 | 6.10x | ₩146.16 Billion | ₩23.97 Billion | ₩74.60 Billion | ▲ +131.8% |
| 2020 | 2.63x | ₩62.78 Billion | ₩23.86 Billion | ₩30.60 Billion | ▲ +160.9% |
| 2019 | 1.01x | ₩23.83 Billion | ₩23.63 Billion | ₩12.04 Billion | ▲ +104.0% |
| 2018 | 0.49x | ₩14.87 Billion | ₩30.08 Billion | ₩8.24 Billion | ▲ +102.7% |
| 2017 | 0.24x | ₩9.09 Billion | ₩37.28 Billion | ₩8.86 Billion | ▲ +13.7% |
| 2016 | 0.21x | ₩10.43 Billion | ₩48.66 Billion | ₩7.80 Billion | ▼ -55.7% |
| 2015 | 0.48x | ₩9.16 Billion | ₩18.94 Billion | ₩7.66 Billion | ▲ +6.4% |
| 2014 | 0.45x | ₩14.74 Billion | ₩32.41 Billion | ₩13.35 Billion | ▼ -61.5% |
| 2013 | 1.18x | ₩8.70 Billion | ₩7.37 Billion | ₩6.83 Billion | — |